Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has shared an update.
WuXi AppTec has convened its 2025 Annual General Meeting for April 28, 2026 in Shanghai, where shareholders will review the 2025 board work report and vote on the annual profit distribution plan and authorization for a mid-year dividend scheme. The agenda also covers approving external guarantees for subsidiaries, renewing Deloitte as onshore and offshore auditor for 2026, re-electing the entire slate of executive, non-executive and independent directors, setting director remuneration, confirming a foreign exchange hedging limit, and amending the 2025 H share award and trust scheme, signaling continued focus on capital returns, risk management and long-term incentive alignment for investors and management.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$124.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-based contract research, development and manufacturing organization serving the global pharmaceutical and biotech industries. Listed in Hong Kong as a Class H share, the company provides integrated R&D and production services that support drug discovery, development and commercialization for international healthcare customers.
Average Trading Volume: 4,962,563
Technical Sentiment Signal: Buy
Current Market Cap: HK$292.3B
See more data about 2359 stock on TipRanks’ Stock Analysis page.